Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Medtronic
Colorcon
AstraZeneca
Mallinckrodt

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Patent: 10,279,034

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 10,279,034
Title:Anti-PD-L1-anti-TIM-3 bispecific antibodies
Abstract: The present invention relates to antibodies that are heterodimeric and bind human PD-L1 and human TIM-3, and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.
Inventor(s): Li; Yiwen (Woodcliff Lake, NJ), Ludwig; Dale Lincoln (Rockaway, NJ), Shen; Yang (Scarsdale, NY), Zhang; Yi (Edison, NJ), D\'Angelo; Igor Edmondo Paolo (Anmore, CA)
Assignee: Eli Lilly and Company (Indianapolis, IN) Zymeworks Inc. (Vancouver, BC, unknown)
Application Number:15/945,011
Patent Claims:see list of patent claims

Details for Patent 10,279,034

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Eli Lilly And Company ERBITUX cetuximab Injection 125084 2004-02-12 ⤷  Try it Free 2039-05-19
Eli Lilly And Company ERBITUX cetuximab Injection 125084 2007-03-28 ⤷  Try it Free 2039-05-19
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKesson
Harvard Business School
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.